Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology | Family Medicine
Clinical Trials: Renal Cell Carcinoma
A listing of clinical trials currently looking for volunteers to enroll in Renal Cell Carcinoma studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Scottsdale : Research Site
AMG 172 First in Human Study in Patients With Kidney Cancer
Scottsdale :
AMG 172 First in Human Study in Patients With Kidney Cancer
Arkansas
Hot Springs : Genesis Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Jonesboro : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
California
Corona : Compassionate Cancer Care Medical Group
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Corona : Compassionate Cancer Care Medical Group, Inc.
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Duarte : City of Hope
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Greenbrae : Marin Specialty Care
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
La Jolla : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Los Angeles : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Los Angeles : Good Samaritan Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Riverside : Compassionate Cancer Care Medical Group
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
San Francisco : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
San Francisco : Ucsf Helen Diller Family Comprehensive Cancer Center
Phase I Biomarker Study (BMS-936558)
San Jose : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Santa Clara : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Stanford : Stanford Cancer Center
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Stanford : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Walnut Creek : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Connecticut
District of Columbia
Washington : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Florida
Fort Myers : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Gainesville : University of Florida, Shands Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Miami Beach : Research Site
A Phase 1 Study to Evaluate MEDI4736
Tampa : Research Site
A Phase 1 Study to Evaluate MEDI4736
Tampa : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Tampa : H Lee Moffitt Cancer Center
Phase I Biomarker Study (BMS-936558)
Georgia
Athens : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Athens : Northeast Georgia Cancer Care, LLC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Augusta : Research Site
A Phase 1 Study to Evaluate MEDI4736
Illinois
Chicago : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Chicago : Northwestern University, Robert H. Lurie Comprehensive Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Chicago : University Of Chicago Medical Center
Phase I Biomarker Study (BMS-936558)
Maywood : Loyola University of Chicago, Cardinal Bernardin Cancer Center
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Indiana
Fort Wayne : Fort Wayne Oncology & Hematology, Inc
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Goshen : IU Health Goshen
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Indianapolis : Community Regional Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Indianapolis : IU Health Central Indiana Cancer Centers
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Lafayette : Horizon Oncology Research
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Muncie : IU Health at Ball Memorial Hospital Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Newburgh : Oncology Hematology Associates of SW Indiana
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
South Bend : Northern Indiana Cancer Research Consortium
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Iowa
Iowa City : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Sioux City : Siouxland Hematology Oncology Associates, LLP, Nylen Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Kansas
Kansas City : University of Kansas Medical Center
A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
Topeka : Stormont-Vail Cotton O'Neil Cancer Center
A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
Wichita : Cancer Center of Kansas
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Wichita : Cancer Center of Kansas
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Louisiana
Baton Rouge : Medical Oncology LLC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Maryland
Baltimore : Sidney Kimmel Comprehensive Cancer Center at John Hopkins Hospital
A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Baltimore : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Baltimore : Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Baltimore : The Bunting-Blaustein Cancer Research Building
Phase I Biomarker Study (BMS-936558)
Massachusetts
Boston : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Boston : Beth Israel Deaconess Medical Center
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
Boston : Dana-Farber Cancer Institute
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
Boston : Beth Israel Deaconess Medical Center
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Boston : Dana-Farber Cancer Institute
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
View More »
Boston : Beth Israel Deaconess Medical Center
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Boston : Beth Israel Deaconess Medical Center
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Boston : Beth Israel Deaconess Medical Center`
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Dana-Farber Cancer Institute
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Massachusetts General Hospital
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Dana Farber Cancer Inst
Phase I Biomarker Study (BMS-936558)
Boston : Massachusetts General Hospital Cancer Center
Safety Study of MGA271 in Refractory Cancer
Burlington : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Michigan
Ann Arbor : St. Joseph Mercy Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Detroit : Karmanos Cancer Institute / Wayne State University
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Detroit : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Detroit : Henry Ford Hospital
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Grand Rapids : Cancer and Hematology Centers of Western Michigan
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Wyoming : Metro Health Cancer Care
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Minnesota
Rochester : Mayo Clinic
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
St. Louis Park : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Missouri
St Louis : Research Site
AMG 172 First in Human Study in Patients With Kidney Cancer
St. Louis : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Nebraska
Lincoln : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Omaha : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Omaha : Methodist Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Omaha : Missouri Valley Cancer Consortium
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Nevada
Las Vegas : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
New Hampshire
Lebanon : Dartmouth-Hitchcock Medical Center
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Manchester : Dartmouth-Hitchcock Medical Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New Jersey
Hackensack : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
New Mexico
Albuquerque : Presbyterian Medical Group
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Albuquerque : University of New Mexico Cancer Care Alliance
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New York
Manhasset : Biomedical Research Alliance of New York, LLC
Study for high risk recurrence of renal cell carcinoma after surgical treatment
View More »
Albany : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Albany : New York Oncology Hematology, PC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Buffalo : Roswell Park Cancer Institute
A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Buffalo : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Buffalo : Roswell Park Cancer Institute
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New York : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
New York : Tisch Cancer Institute at Mount Sinai Medical Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
New York : Memorial Sloan Kettering Cancer Center
Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
North Carolina
Chapel Hill : North Carolina Cancer Hospital (UNC)
Neoadjuvant Pazopanib in Renal Cell Carcinoma
Charlotte : Blumenthal Cancer Center
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Charlotte : Carolinas HealthCare System
Neoadjuvant Pazopanib in Renal Cell Carcinoma
Durham : Duke University Medical Center
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Durham : Duke University Medical Center
Phase I Biomarker Study (BMS-936558)
Ohio
Cleveland : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Cleveland : Cleveland Clinic
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Cleveland : Cleveland Clinic, Taussig Cancer Institute
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Columbus : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Middletown : Signal Point Clinical Research Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Oklahoma
Oklahoma City : Mercy Physicians Of Oklahoma
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Oregon
Portland : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Portland : Providence Portland Med Ctr
Phase I Biomarker Study (BMS-936558)
Springfield : Willamette Valley Cancer Institute
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Pennsylvania
Gettysburg : Gettysburg Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Philadelphia : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Philadelphia : Fox Chase Cancer Center
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Philadelphia : Fox Chase Cancer Center
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Philadelphia : Fox Chase Cancer Center
Phase I Biomarker Study (BMS-936558)
View More »
Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center
Safety Study of MGA271 in Refractory Cancer
Pittsburgh : Allegheny Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Pittsburgh : Upmc Cancer Pavilion
Phase I Biomarker Study (BMS-936558)
Rhode Island
Providence : Miriam Hospital, The
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Providence : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
South Carolina
Charleston : MUSC Hollings Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Charleston : Medical University of South Carolina (MUSC)
Neoadjuvant Pazopanib in Renal Cell Carcinoma
Myrtle Beach : Carolina Urologic Research Center
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Tennessee
Chattanooga : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Germantown : The Jones Clinic, PC
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Memphis : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Nashville : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Nashville : Vanderbilt Univeristy Medical Center
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
View More »
Nashville : Tennessee Oncology, Pllc
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Nashville : Sarah Cannon Research Institute
Safety Study of MGA271 in Refractory Cancer
Texas
Austin : Texas Oncology: Austin North
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Bedford : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Bedford : Texas Oncology: Bedford
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Dallas : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Dallas : Texas Oncology, PA
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Fort Worth : Texas Oncology: Fort Worth
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Houston : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Houston : Houston Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Houston : Texas Oncology: Houston Memorial City
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Lubbock : Joe Arrington Cancer Research and Treatment Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
San Antonio : CTRC at The UT Health Science Center at San Antonio
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Tyler : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Virginia
Norfolk : Urology of Virginia
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Virginia Beach : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Washington
Bremerton : Harrison HealthPartners Bremerton Hematology & Oncology
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Kirkland : Cascade Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Seattle : Seattle Cancer Care Alliance / University of Washington
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Seattle : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Seattle : Group Health Medical Centers
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
View More »
Seattle : University of Washington, Seattle Cancer Care Alliance
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Spokane : Rockwood Clinic
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Wisconsin
Madison : University Of Wisconsin Carbone Cancer Center
Phase I Biomarker Study (BMS-936558)
Milwaukee : University of Wisconsin, Clinical Cancer Center
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Algeria
Algiers : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Argentina
Capital Federal : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ciudad Aut6noma de Buenos Aires : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ciudad Autonoma de Buenos Aires : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Córdoba : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Quilmes : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Rosario : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
San Miguel de Tucumán : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Santa Fe : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Australia
Greenslopes : Gallipoli Medical Research Foundation: Greenslopes Private Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Kurralta Park : Ashford Cancer Centre
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Launceston : Gallipoli Medical Research Foundation: Launceston General Hospital
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Austria
Salzburg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Vienna : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Belgium
Hasselt : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Liège : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Wilrijk : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Brazil
Barretos : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Belo Horizonte : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Curitiba : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ijui : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Porto Alegre : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Rio de Janeiro : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
São Paulo : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Canada
Calgary : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Calgary : Local Institution
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Edmonton : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Edmonton : Local Institution
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Halifax : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Hamilton : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
London : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Moncton : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Montreal : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Oshawa : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ottawa : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Quebec : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Toronto : University Health Network, Princess Margaret Hospital
A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
Toronto : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Toronto : Toronto General Hospital
Efficacy of Ultrasound Contrast Agent to Assess Renal Masses
Vancouver : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Vancouver : Local Institution
BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Chile
Santiago : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Viña del Mar : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
China
Beijing : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Hangzhou : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Shanghai : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Tianjin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Wuhan : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Czech Republic
Brno : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Hradec Kralove : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Novy Jicin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Olomouc : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ostrava - Poruba : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Plzen : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Praha 2 : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Praha 8 : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Denmark
Aarhus : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
DK-2730 Herlev : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Odense C : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Egypt
Cairo : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
France
Angers cedex 9 : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Besançon cedex : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Bordeaux : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Caen Cedex 05 : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Hyeres : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Le Mans : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Marseille cedex 5 : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Montpellier Cedex 5 : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Paris : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Paris Cedex 15 : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Reims : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Rennes : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Saint Herblain : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Strasbourg cedex : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Toulouse : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Villejuif : Research Site
AMG 172 First in Human Study in Patients With Kidney Cancer
Germany
Aachen : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Berlin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Berlin : Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30
Exercise for Patients With Renal Cell Cancer Receiving Sunitinib
Bonn : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Braunschweig : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Bremen : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Chemnitz : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Dessau : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Duisburg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Eisleben : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Erlangen : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Essen : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Freiburg : iOMEDICO
Tumor Registry of Advanced Renal Cell Carcinoma
Goslar : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Halle : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Hamburg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Hannover : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Heidelberg : Research Site
AMG 172 First in Human Study in Patients With Kidney Cancer
Homburg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Jena : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Kirchheim : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Mainz : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Marburg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Moenchengladbach : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Muenchen : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Muenster : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Neuss : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Offenbach : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Sigmaringen : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Stuttgart : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Tuebingen : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ulm : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Velbert : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Weiden : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Greece
Athens : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Heraklion, Crete : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Patra : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Thessaloniki : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Hungary
Budapest : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Nyíregyháza : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Szombathely : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ireland
Co.Cork : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Cork : Cork University Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Dublin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Dublin : Mater Misericordiae University Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Dublin : Mater Private Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
View More »
Dublin : The Adelaide & Meath Hospital Dublin incorporating the National Children's Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Dublin : Beaumont Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Galway : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Galway : Galway University Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Limerick : Mid-Western Regional Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Tallaght, Dublin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Waterford : Waterford Regional Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Israel
Haifa : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Jerusalem : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Petach-Tikva : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Rehovot : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Tel Aviv : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Zrifin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Italy
Arezzo : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Bologna : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Candiolo (TO) : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Meldola (FC) : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Milano : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Modena : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Napoli : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Pavia : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Roma : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Terni : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Japan
Fukuoka : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Fukuoka-shi : Kyusyu University Hospital
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Hokkaido : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Okayama : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Osaka : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Osakasayama : Kinki University Hospital
Temsirolimus (Torisel) Special Investigation (Regulatory Post Marketing Commitment Plan)
Shizuoka : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Tokyo : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Yamagata : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Korea, Republic of
Daejeon : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Goyang-si, Gyeonggi-do : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Jeonju : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Seongnam-si, : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Seoul : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
songpa-gu, Seoul : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Luxembourg
Luxembourg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Poland
Gdansk : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Konin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Krakow : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Lublin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Warszawa : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Wroclaw : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Russian Federation
Arkhangelsk : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Barnaul : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Chelyabinsk : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ekaterinburg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Kazan : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Moscow : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Obninsk : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Omsk : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Rostov-na-Donu : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ryazan : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Saint Petersburg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
St. Petersburg : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Stavropol : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Ufa, : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Slovakia
Banska Bystrica : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Bratislava : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Kosice : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Martin : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Zilina : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
South Africa
Cape Town : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Durban : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Johannesburg : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Spain
Badalona : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Barcelona : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Córdoba : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Dos Hermanas (Sevilla) : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Madrid : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Málaga : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Oviedo : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Sevilla : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Valencia : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Sweden
Stockholm : Karolinska University Hospital
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Thailand
Bangkok : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Chaingmai : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Songkla : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Tunisia
Ariana : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Sousse : Novartis Investigative Site
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma
Turkey
Ankara : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Istanbul : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Izmir : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Many Locations :
Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma
United Kingdom
Brighton : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Cambridge : Cambridge University Hospitals NHS Foundation Trust
HYPAZ: Hypertension Induced by Pazopanib
Cornwall : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Guildford : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
London : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
View More »
Manchester : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Preston : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Swansea : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Wolverhampton : GSK Investigational Site
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
